Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2018

Related Party Transactions [Abstract]

Schedule of Aggregate Use of Fees Charged

In the aggregate, BioTime charged Use Fees to OncoCyte as follows (in thousands):

	Year Ended December 31,
	2018		2017
Research and development	$	882	$	1,085
General and administrative		375		268
Sales and marketing		310		213
Total use fees	$	1,567	$	1,566